Corvus Pharmaceuticals Inc
NASDAQ:CRVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
|
US |
|
H
|
Hextar Capital Bhd
KLSE:HEXCAP
|
MY |
|
Bank Bumi Arta Tbk PT
IDX:BNBA
|
ID |
|
Kulicke and Soffa Industries Inc
NASDAQ:KLIC
|
SG |
|
C
|
Curacle Co Ltd
KOSDAQ:365270
|
KR |
|
Sunrun Inc
NASDAQ:RUN
|
US |
|
D
|
Dongil Technology Ltd
KOSDAQ:032960
|
KR |
|
Taboola.com Ltd
F:1FY
|
US |
|
Merdeka Copper Gold Tbk PT
F:B0C
|
ID |
|
I
|
IBI-Lion SOCIMI SA
MAD:YIBI
|
ES |
|
N
|
Norfolk Southern Corp
LSE:0K8M
|
US |
|
Solaredge Technologies Inc
NASDAQ:SEDG
|
IL |
|
D
|
Diamondrock Hospitality Co
F:HBO
|
US |
|
W
|
West Pharmaceutical Services Inc
SWB:WPS
|
US |
|
Exmceuticals Inc
F:9OM1
|
CA |
|
Four Corners Property Trust Inc
NYSE:FCPT
|
US |
|
MS&AD Insurance Group Holdings Inc
OTC:MSADF
|
JP |
|
S
|
Square Enix Holdings Co Ltd
TSE:9684
|
JP |
|
M
|
MW Trade SA
WSE:MWT
|
PL |
|
Critical Elements Lithium Corp
F:F12
|
CA |
|
C
|
Conrad Asia Energy Ltd
ASX:CRD
|
ID |
Bankruptcy Probability
Corvus Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Corvus Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
|
1.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
54.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
46.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Corvus Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Corvus Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
